31 marzo 2020

COVID-19: CRS4 MASSIVE SEQUENCING FACILITY AVAILABLE FOR STUDIES ON SARS-COV-2

The CRS4 (Center for Advanced Studies, Research and Development in Sardinia) opens to international collaboration with partners who want to test the use of genomic sequencing, bioinformatics and data analysis technologies. The machines of the NEXT massive sequencing facility located in the Technology Park of Pula (Cagliari), will be made available to researchers from all over the world who will have the opportunity to request access remotely with a priority procedure - i.e. without having to physically move to the Pula laboratories - to carry out experiments useful for studying and developing new diagnostic methodologies, new therapies, carrying out sequence studies to support the development of vaccines, identifying the best treatments for the treatment of the disease, supporting epidemiological monitoring useful for modulating the impact of public health interventions, using massive sequencing technologies on samples of non-pathogenic nucleic acids.
The call is highlighted in the homepage of the NEXT Laboratory.
For further information: Giorgio Fotia, CRS4, Director of Biosciences and NEXT Platform. 
E-mail: covid19-next@crs4.it

Nessun commento: